JP2016528926A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528926A5
JP2016528926A5 JP2016539666A JP2016539666A JP2016528926A5 JP 2016528926 A5 JP2016528926 A5 JP 2016528926A5 JP 2016539666 A JP2016539666 A JP 2016539666A JP 2016539666 A JP2016539666 A JP 2016539666A JP 2016528926 A5 JP2016528926 A5 JP 2016528926A5
Authority
JP
Japan
Prior art keywords
lactobacillus
microorganism
composition
placebo
ingestion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539666A
Other languages
English (en)
Japanese (ja)
Other versions
JP6701078B2 (ja
JP2016528926A (ja
Filing date
Publication date
Priority claimed from IT001473A external-priority patent/ITMI20131473A1/it
Application filed filed Critical
Publication of JP2016528926A publication Critical patent/JP2016528926A/ja
Publication of JP2016528926A5 publication Critical patent/JP2016528926A5/ja
Application granted granted Critical
Publication of JP6701078B2 publication Critical patent/JP6701078B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539666A 2013-09-06 2014-09-05 微生物を含む組成物の腸内微生物叢に対する効果の評価方法 Expired - Fee Related JP6701078B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2013A001473 2013-09-06
IT001473A ITMI20131473A1 (it) 2013-09-06 2013-09-06 Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale
PCT/IB2014/064284 WO2015033304A1 (en) 2013-09-06 2014-09-05 Method for evaluating the effects of a composition comprising microorganisms on intestinal microbiota

Publications (3)

Publication Number Publication Date
JP2016528926A JP2016528926A (ja) 2016-09-23
JP2016528926A5 true JP2016528926A5 (https=) 2017-10-19
JP6701078B2 JP6701078B2 (ja) 2020-05-27

Family

ID=49354801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539666A Expired - Fee Related JP6701078B2 (ja) 2013-09-06 2014-09-05 微生物を含む組成物の腸内微生物叢に対する効果の評価方法

Country Status (13)

Country Link
US (1) US20160348155A1 (https=)
EP (1) EP3047032A1 (https=)
JP (1) JP6701078B2 (https=)
CN (1) CN105518150A (https=)
BR (1) BR112016005064A2 (https=)
CA (1) CA2923390A1 (https=)
EA (2) EA202090097A1 (https=)
HK (1) HK1223982A1 (https=)
IL (1) IL244391B (https=)
IT (1) ITMI20131473A1 (https=)
MX (2) MX2016002766A (https=)
SG (1) SG11201601664VA (https=)
WO (1) WO2015033304A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
KR102719722B1 (ko) * 2015-10-29 2024-10-18 가부시키가이샤 야쿠르트 혼샤 에쿠올 산생능의 측정 방법
IT201600083376A1 (it) 2016-08-08 2018-02-08 Sofar Spa Uso di probiotici per aumentare l’assorbimento proteico
ITUA20164188A1 (it) 2016-06-08 2017-12-08 Sofar Spa Nuovo uso medico di probiotici
CN106318890A (zh) * 2016-10-21 2017-01-11 山东省农业科学院畜牧兽医研究所 一株分离自spf鸡嗉囊的产植酸酶卷曲乳杆菌菌株及其应用
IT201600122724A1 (it) * 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
IT201700101704A1 (it) * 2017-09-12 2019-03-12 Sofar Spa Nuovo uso per trattamento delle infezioni da clostridium difficile
MX2020007619A (es) * 2018-01-17 2020-09-28 Consorcio Centro De Investig Biomedica En Red M P Intervenciones dirigidas, encaminadas a reducir los niveles de succinato circulante en un sujeto, y kits y metodo para determinar la eficacia de dichas intervenciones.
CN112384227A (zh) 2018-02-09 2021-02-19 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
WO2019195342A1 (en) * 2018-04-02 2019-10-10 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
CN110029155A (zh) * 2019-05-27 2019-07-19 天益健康科学研究院(镇江)有限公司 一种基于荧光定量pcr组合式肠道细菌检测方法
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN112980712A (zh) * 2019-12-14 2021-06-18 山东大学 一种调节高原人群情绪及肠道菌群稳定的微生物组合物及其应用
CN116287163A (zh) * 2023-02-17 2023-06-23 浙江大学 一种评估肠道菌群对菊粉的动态响应方法
EP4575491A1 (en) 2023-12-22 2025-06-25 Vilnius University Method for detecting volatile organic compounds in faecal matter odour

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
WO2005001109A2 (en) * 2003-05-06 2005-01-06 Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health Methods and compositions to detect microbes in fecal samples
AU2005217124A1 (en) * 2004-02-27 2005-09-09 Stichting Laboratorium Voor Infectieziekten Method for detecting a microorganism in a fecal specimen
US20090197249A1 (en) * 2004-11-01 2009-08-06 George Mason University Compositions and methods for diagnosing colon disorders
FI20051319L (fi) * 2005-12-22 2007-06-23 Cyflo Oy Menetelmä eläimen ja/tai ihmisen ravitsemuksen ja hyvinvoinnin ja eläinten tuottavuuden seuraamiseksi ja kehittämiseksi
CN1840206A (zh) * 2006-01-19 2006-10-04 上海交通大学 人源菌群仔猪模型的构建及仔猪肠道中菌群分子检测方法
EP1997886B1 (en) * 2006-02-21 2013-06-05 National University Corporation University of Toyama Rapid method for identifying causative microorganism of infectious disease
CN101240315A (zh) * 2008-02-21 2008-08-13 上海交通大学 检测药物防癌效果的非损伤性分子方法
JP2010161944A (ja) * 2009-01-13 2010-07-29 Syngen Biotech Co Ltd 新型カゼイ菌の亜種(sg96)及びこれを含有する菌抑制組成物及びその用途

Similar Documents

Publication Publication Date Title
JP2016528926A5 (https=)
Dal Bello et al. Increased complexity of the species composition of lactic acid bacteria in human feces revealed by alternative incubation condition
Bengoa et al. Kefir micro‐organisms: their role in grain assembly and health properties of fermented milk
Rossi et al. Mining metagenomic whole genome sequences revealed subdominant but constant Lactobacillus population in the human gut microbiota
Felis et al. Taxonomy of lactobacilli and bifidobacteria
Pot et al. The genus Lactobacillus
Magalhaes et al. Microbial communities and chemical changes during fermentation of sugary Brazilian kefir
Dal Bello et al. Oral cavity as natural reservoir for intestinal lactobacilli
Simpson et al. Bifidobacterium psychraerophilum sp. nov. and Aeriscardovia aeriphila gen. nov., sp. nov., isolated from a porcine caecum
Drago et al. Cultivable and pyrosequenced fecal microflora in centenarians and young subjects
Montesi et al. Molecular and microbiological analysis of caecal microbiota in rats fed with diets supplemented either with prebiotics or probiotics
ES2616334T3 (es) Probióticos, IgA secretora e infección
JP6701078B2 (ja) 微生物を含む組成物の腸内微生物叢に対する効果の評価方法
Gesudu et al. Investigating bacterial population structure and dynamics in traditional koumiss from Inner Mongolia using single molecule real-time sequencing
JP2024026410A5 (https=)
JP2011518873A5 (https=)
Quartieri et al. Comparison of culture-dependent and independent approaches to characterize fecal bifidobacteria and lactobacilli
Marzotto et al. Lactobacillus paracasei A survives gastrointestinal passage and affects the fecal microbiota of healthy infants
Hedberg et al. Prevotella jejuni sp. nov., isolated from the small intestine of a child with coeliac disease
Matsumoto et al. Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt
Paek et al. Lacticaseibacillus kribbianus sp. nov., isolated from pig farm faeces dump
Bai et al. Lacticaseibacillus absianus sp. nov., isolated from the cecum of a mini-pig
Kim et al. Development of rapid and highly specific TaqMan probe-based real-time PCR assay for the identification and enumeration of Lactobacillus kefiri in kefir milk
Vankerckhoven et al. Establishment of the PROSAFE collection of probiotic and human lactic acid bacteria
Cousin et al. Lactobacillus pasteurii sp. nov. and Lactobacillus hominis sp. nov.